Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies. [electronic resource]
Producer: 20060127Description: 224-9 p. digitalISSN:- 0925-5710
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Arsenic Trioxide
- Arsenicals -- administration & dosage
- Bone Marrow -- pathology
- Female
- Humans
- Japan
- Leukemia, Promyelocytic, Acute -- complications
- Male
- Middle Aged
- Neoplasm Proteins -- biosynthesis
- Oncogene Proteins, Fusion -- biosynthesis
- Oxides -- administration & dosage
- Recurrence
- Remission Induction
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.